Replies to post #2877 on UniCycive Therapeutics Inc (UNCY)

[Whalatane]

Yes , especially in the Cardiovascular and Kidney disease field ...I pay more attention if any one of the following 3 are involved

Top-Tier Biotech Investors
RA Capital Management: Often cited as one of the most active and successful biotech venture investors, RA Capital frequently leads both the number of funding rounds and total dollars invested in the industry. They are known for a data-driven approach and a large portfolio that spans both private and public markets.

Baker Bros. Advisors: Julian and Felix Baker are legendary figures in biotech investing. Their hedge fund is renowned for a long-term, concentrated investment strategy in public life science companies. They have a history of significant "winners" (e.g., InterMune, Incyte) and are frequently backed by major university endowments.

Specialized and Successful Peer Firms
Vivo Capital: A highly successful and established firm that focuses on both public and private investments in the healthcare and biotechnology sectors across the U.S. and Asia. They are often recognized for their cross-border expertise and growth-stage investments.

Vivo as you know were early in UNCY

Kiwi